TAK
Takeda Pharmaceutical Stock Analysis
AI Rating
- Quality6/10
- Growth↑ 6/10
- Value↓ 3/10
TAK Growth
- Revenue Y/Y↓ -1.31%
- EPS Y/Y↑ 78.10%
- FCF Y/Y↑ 5.27%
TAK Profitability
- Gross margin ↑ 65.10%
- EPS margin↓ 4.30%
- ROIC 5Y↓ 5.42%
TAK Dividends
- Dividend yield 0.00%
- Growth 3Y↓ -27.41%
- Payout ratio↑ 1%
TAK Risk
- Debt / Equity↓ 0.7
- Debt / FCF↑ 5.8
- Interest coverage↓ 1.7
Takeda Pharmaceutical stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.